We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.33B
1-Year Est. Return 18.98%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+18.98%
3 Year Est. Return
+55.21%
5 Year Est. Return
+46.72%
10 Year Est. Return
+185.29%
AUM
$2.13B
AUM Growth
+$162M
Cap. Flow
+$135M
Cap. Flow %
6.32%
Top 10 Hldgs %
74.03%
Holding
303
New
12
Increased
145
Reduced
81
Closed
18

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$1.04M
2
CVS icon
CVS Health
CVS
+$650K
3
CIVB icon
Civista Bancshares
CIVB
+$555K
4
MMM icon
3M
MMM
+$392K
5
UL icon
Unilever
UL
+$357K

Sector Composition

Rank Sector Weight
1 Technology 7.84%
2 Financials 7.12%
3 Consumer Staples 1.93%
4 Healthcare 1.77%
5 Consumer Discretionary 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
301
Thermo Fisher Scientific
TMO
$214B
-366
Closed -$213K
VXF icon
302
Vanguard Extended Market ETF
VXF
$30B
-1,165
Closed -$204K
WBA
303
DELISTED
Walgreens Boots Alliance
WBA
-10,236
Closed -$222K

Similar funds

Nicholas Hoffman & Company's Q2 2024 Portfolio in Review

As of Q2 2024, Nicholas Hoffman & Company held 303 positions worth $2.13B, up 8.2% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Nicholas Hoffman & Company deployed $135M of net new capital in Q2 2024, opening 12 new positions and adding to 145 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.7% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Accenture, an estimated $1.04M trimmed.

  • Nicholas Hoffman & Company's largest Q2 2024 buy was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
  • Nicholas Hoffman & Company added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $41.8M increase.
  • Nicholas Hoffman & Company's biggest Q2 2024 reduction was Accenture, cutting an estimated $1.04M.
  • Nicholas Hoffman & Company fully exited CVS Health in Q2 2024, selling an estimated $650K.
  • Nicholas Hoffman & Company's ten largest holdings make up 74% of its $2.13B portfolio in Q2 2024.
  • Nicholas Hoffman & Company opened 12 new positions and closed 18 in Q2 2024.
  • Nicholas Hoffman & Company's portfolio value rose 8.2% quarter-over-quarter to $2.13B.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2024, filed 2 Aug 2024.